Home > Insider Trading > Filing (0001104659-13-070475)

Filing Details

Accession Number:: 0001104659-13-070475
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-17 16:33:31
Reporting Period:: 2013-09-13

Filing Date:: 2013-09-17
Accepted Time:: 2013-09-17 16:33:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386858	Hyperion Therapeutics Inc	HPTX	Pharmaceutical Preparations (2834)	611512713

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1343244	P L Vii-B Partners Capital Highland	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1343673	Highland Capital Partners Vii-C Lp	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1343678	Highland Capital Partners Vii Lp	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1357840	Partnership Limited Vii Fund Entrepreneurs Highland	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1554026	Highland Management Partners Vii, Llc	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No
1554027	Partnership Limited Vii Partners Management Highland	C/O Highland Capital Partners, One Broadway, 16Th Floor Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-09-13	1,291	$26.50	1,249,626	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-13	313	$26.50	302,805	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-13	456	$26.50	440,979	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-13	40	$26.50	39,145	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-16	3,812	$26.22	1,245,814	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-16	924	$26.22	301,881	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-16	1,345	$26.22	439,634	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2013-09-16	119	$26.22	39,026	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

The securities are held by Highland Capital Partners VII Limited Partnership ("HCP VII"). Highland Management Partners VII, LLC ("HMP VII LLC") is the general partner of Highland Management Partnership VII Limited Partnership ("HMP VII LP"), which is the general partner of HCP VII. Each of HMP VII LP and HMP VII LLC disclaims beneficial ownership of all shares held by HCP VII except to the extent, if any, of such entity's pecuniary interest therein.
The securities are held by Highland Capital Partners VII-B Limited Partnership ("HCP VII-B"). HMP VII LP is the general partner of HCP VII-B. Each of HMP VII LP and HMP VII LLC disclaims beneficial ownership of all shares held by HCP VII-B except to the extent, if any, of such entity's pecuniary interest therein.
The securities are held by Highland Capital Partners VII-C Limited Partnership ("HCP VII-C"). HMP VII LP is the general partner of HCP VII-C. Each of HMP VII LP and HMP VII LLC disclaims beneficial ownership of all shares held by HCP VII-C except to the extent, if any, of such entity's pecuniary interest therein.
The securities are held by Highland Entrepreneurs' Fund VII Limited Partnership ("HEF VII"). HMP VII LP is the general partner of HEF VII. Each of HMP VII LP and HMP VII LLC disclaims beneficial ownership of all shares held by HEF VII except to the extent, if any, of such entity's pecuniary interest therein.
This price represents the weighted average of sales ranging from $26.25 to $26.61. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $26.10 to $26.31. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.